G

Galectin Therapeutics
D

GALT

4.34000
USD
0.12
(2.84%)
مغلق
حجم التداول
13,760
الربح لكل سهم
-0
العائد الربحي
-
P/E
-7
حجم السوق
278,021,537
أصول ذات صلة الأخبار المقالات

العنوان: Galectin Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.